Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

114
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
114
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

929
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
929
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Acute Pharyngitis01:30

Acute Pharyngitis

540
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
540
Stages of Infection01:26

Stages of Infection

56.0K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
56.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza.

Influenza and other respiratory viruses·2026
Same author

Impact of regional heterogeneity of RSV infection prophylaxis on bronchiolitis in Italy.

Italian journal of pediatrics·2026
Same author

Clinical Features and Predictors of Severity in Children Hospitalized With Human Metapneumovirus: A Multicenter Italian Study.

The Pediatric infectious disease journal·2026
Same author

Appropriateness and Abuse of Antipyretics, Anti-Inflammatory Drugs and Antibiotics in Children and Adults.

Antibiotics (Basel, Switzerland)·2026
Same author

Inter-society consensus on the management of acute bloody diarrhea and shiga toxin-producing Escherichia coli infection in the molecular microbiology era.

Italian journal of pediatrics·2026
Same author

Phenotyping Pediatric Long COVID: Symptom Clusters from a Longitudinal Multicenter Italian Cohort.

Children (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 19, 2025

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

908

Acute Infectious Diarrhea.

Marco Poeta1, Margherita Del Bene1, Andrea Lo Vecchio1

  • 1Department of Translational Medical Sciences - Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Advances in Experimental Medicine and Biology
|July 26, 2024
PubMed
Summary

Probiotics are effective for treating acute infectious diarrhea (AID) in children, with specific strains and early intervention being key. Their preventative role is more suited for at-risk populations and hospital-acquired infections.

Keywords:
DiarrheaGastroenteritisGastrointestinal infectionsProbiotics

More Related Videos

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

5.5K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.1K

Related Experiment Videos

Last Updated: Jun 19, 2025

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

908
Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells
08:56

Imaging Ca2+ Responses During Shigella Infection of Epithelial Cells

Published on: May 24, 2018

5.5K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.1K

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Acute infectious diarrhea (AID) poses a significant global health burden in children.
  • Probiotics offer a promising therapeutic avenue for AID due to their multifaceted actions on the gut.
  • Strain-specific efficacy and appropriate indications are crucial for successful probiotic intervention.

Purpose of the Study:

  • To review the mechanisms of action of probiotics in childhood AID.
  • To evaluate the evidence supporting probiotic use in the prevention and treatment of AID.
  • To discuss emerging research on probiotics, postbiotics, and their impact on specific diarrheal conditions.

Main Methods:

  • Literature review and synthesis of existing research on probiotics for AID.
  • Analysis of clinical trial data and expert guidelines.
  • Discussion of novel findings, including rotavirus immunization interactions and COVID-associated diarrhea.

Main Results:

  • Probiotic therapy for AID is a well-established indication, particularly for treatment.
  • Selected probiotic strains demonstrate efficacy and safety when used early in AID management.
  • Prevention of AID is supported in hospital-acquired settings and for at-risk children, but less so in healthy populations.

Conclusions:

  • The strongest evidence for probiotic use in pediatric gastrointestinal disorders lies in treating AID.
  • Early administration of effective probiotic strains is recommended for optimal outcomes in childhood AID.
  • Further research is needed to clarify the role of probiotics in AID prevention in diverse settings.